BETAHISTINE-ZP betahistine dihydrochloride 8mg tablets blister pack

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

betahistine dihydrochloride, Quantity: 8 mg

Dostępny od:

Medis Pharma Pty Ltd

INN (International Nazwa):

betahistine dihydrochloride

Forma farmaceutyczna:

Tablet

Skład:

Excipient Ingredients: stearic acid; crospovidone; colloidal anhydrous silica; povidone; lactose monohydrate; microcrystalline cellulose

Droga podania:

Oral

Sztuk w opakowaniu:

100 tablets, 10 tablets, 25 tablets

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Podsumowanie produktu:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B8 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Status autoryzacji:

Licence status A

Data autoryzacji:

2015-11-10